Cargando…

Sarcoma of the female genitalia. Volume 2, Other Rare Sarcomas, Mixed Tumors, Genital Sarcomas and Pregnancy /

The subject matter of volume 2 of the 2-volumes-handbook focusses especially on rare sarcomas of the whole female genitalia. These entities include angiosarcoma, the different lipo- and rhabdomyosarcoma as well as newer entities like the PEComa. Furthermore, mixed mullerian tumors like the benign ad...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Koehler, Guenter (Gynecologist) (Autor), Evert, Matthias (Autor), Evert, Katja (Autor), Zygmunt, Marek (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Alemán
Publicado: Berlin ; Boston : De Gruyter, [2016]
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Foreword ; Contents ; List of abbreviations ; Definition of cytoreduction, NCCN-Guidelines ; Immunohistochemistry table ; 1 Angiosarcoma ; 1.1 Uterine angiosarcoma ; 1.1.1 General, epidemiology, etiology, pathogenesis, staging ; 1.1.2 Macroscopic and microscopic features.
  • 1.1.3 Clinical presentation, diagnostics, screening 1.1.4 Imaging ; 1.1.5 Differential diagnostics ; 1.1.6 Course, prognosis ; 1.1.7 Primary surgery ; 1.1.8 Adjuvant and additive radio-, chemo- and hormone therapy.
  • 1.1.9 Primary radio-, chemo- and hormone therapy, approach in cases of general inoperability 1.1.10 Aftercare, recurrences, metastases ; 1.1.11 Surgery and postoperative additive therapy for recurrences and metastases.
  • 1.1.12 Palliative radio-, chemo- and hormone therapy, small molecule therapy, supportive therapy 1.2 Extrauterine angiosarcomas ; 1.2.1 Angiosarcomas of the vulva and the vagina ; 1.2.2 Angiosarcoma of the ovary and the tuba uterina ; 2 Liposarcoma ; 2.1 Uterine liposarcoma.
  • 2.1.1 General, epidemiology, etiology, pathogenesis, staging 2.1.2 Macroscopic and microscopic features ; 2.1.3 Clinical presentation, diagnostics, screening ; 2.1.4 Imaging ; 2.1.5 Differential diagnostics ; 2.1.6 Course, prognosis ; 2.1.7 Primary surgery.
  • 2.1.8 Adjuvant and additive radio-, chemo- and hormone therapy.